MUNOZ, M. Aprepitant, When Used with Chemotherapy, Reduces the Risk of Recurrence, Metastasis, And Mortality in Patients with Breast Cancer: Aprepitant in Breast Cancer Outcomes. Pakistan Journal of Health Sciences, Pakistan, v. 7, n. 8, p. 01–02, 2026. DOI: 10.54393/pjhs.v7i8.4537. Disponível em: https://thejas.com.pk/index.php/pjhs/article/view/4537. Acesso em: 1 sep. 2026.